AUG. 10, 2019

Obliteride Funding in Action

100% of dollars raised go to powerful research at Fred Hutch.

In 2019, Obliteride raised more than $3 million for groundbreaking research at Fred Hutch. Cures start here — because of you.
Your support turns compassion into action at Fred Hutch!

From improving prevention to advancing lifesaving treatments, your Obliteride dollars have funded more than $17 million for groundbreaking research over seven years. Every dollar you raise fuels leading-edge science at Fred Hutchinson Cancer Research Center.
Your support allows our researchers to pursue the bold ideas and new discoveries that can lead to cures. Here are just some of the amazing scientists and projects 2018 dollars are supporting.
Meet more of our researchers

Want to learn more? Get to know researchers funded by 2018 Obliteride dollars below. 

Igniting discovery

Obliteride dollars fuel game-changing ideas that can transform medicine and become cures.

Trevor Bedford
Vaccine and Infectious Disease Division

Understanding viruses
Dr. Trevor Bedford is developing powerful tools to track viral disease outbreaks and studying how viruses  mutate to evade our immune system. These insights could deepen our understanding of how cancers — just like viruses — grow and evade detection, and how we might intercept them. 

Brandon Hadland
Clinical Research Division
Decoding blood cancers
Dr. Brandon Hadland studies how blood stem cells — the immature cells that give rise to all our blood and immune cells — form in the body. Ultimately, he hopes to create a system that can generate these cells in the lab, a capability that could spur new treatments for patients with blood cancer or whose stem cells have been depleted by harsh chemotherapies.

Meghan Koch
Basic Sciences Division
Managing microbes
Dr. Meghan Koch is learning how breast milk influences newborns’ health — from conferring early protection against some diseases to improving digestion. Intriguingly, this research may also offer new understandings about how our adult immune systems interact with the microbes in our bodies to improve or harm our health.

Powering prevention

With your support, Hutch scientists are finding new ways to stop cancer before it starts.

Holly Harris
Public Health Sciences Division
Check out this video from Holly

Exploring risk factors
How might lifestyle and genetic factors affect a woman’s risk for breast and ovarian cancer? Dr. Holly Harris is finding out. By putting a laser focus on these factors, her work is giving women new information for decisions about risk, prevention, and screening.

Jaimee Heffner
Public Health Sciences Division
Preventing cancer
Dr. Jaimee Heffner is applying gold-standard science to create data-based, compassionate, and effective apps to help people quit smoking and lower their risk of cancer. When people say it can’t be done, Dr. Heffner finds new ways to make it possible.

Andy McGuire
Vaccine and Infectious Disease Division

Attacking cancer-causing virus
Dr. Andy McGuire is an expert on Epstein-Barr virus (EBV), an extremely common and often harmless disease that, for reasons that are not fully understood, can cause cancer. In fact, EBV causes an estimated 200,000 new cancer cases and 140,000 deaths each year. Dr. McGuire hopes to develop a vaccine to prevent EBV — and the cancers it can cause — as well as immunotherapies to help people facing these cancers.

Akhila Rajan
Basic Sciences Division
Combating obesity and cancer
Obesity and cancer are linked — but how to kick the weight? Dr. Akhila Rajan is investigating how the misregulation of a hormone called leptin may contribute to obesity. Her insights could unlock new ways to help people fight obesity and, by extension, lower their cancer risk.

Advancing treatment — and cures

With you beside us, our researchers are advancing cancer cures and making treatments safer, less difficult, and more effective.

Joshua Hill
Clinical Research and Vaccine and Infectious Disease Divisions
Fighting deadly infections
Dr. Josh Hill examines the causes of life-threatening infections in patients with compromised immune systems. By developing powerful new therapies to prevent and treat these infections, he is increasing survival and improving quality of life for transplant patients.

Andrew Hsieh
Human Biology and Clinical Research Divisions
Tackling difficult cancers
Dr. Andrew Hsieh is deciphering how cancer cells tick and finding therapies for understudied and hard-to-treat cancers. His work on bladder cancer, for example, is yielding new insights into the inner workings of a devastating disease that has long eluded researchers.

Salene Jones
Public Health Sciences Division
Helping where it hurts
Cancer treatments save lives, but they can be very hard on patients. Dr. Salene Jones is looking closely at the personal and environmental factors that affect people’s quality of life as they face cancer. Her goal? Therapeutic approaches that treat the whole person by reducing anxiety and depression during treatment.

Jerry Radich
Clinical Research Division
Personalizing leukemia treatment
Dr. Jerry Radich’s focus is on creating new tools to improve the diagnosis and treatment of two types of blood cancer: chronic and acute myeloid leukemia. Currently, he is developing a test that analyzes a patient's leukemia cells to identify their best treatment options and predict their risk of relapse, giving clinicians new ways to improve and customize care.

Thomas Uldrick
Vaccine and Infectious Disease Division

Combatting cancer globally
By studying the estimated one-fifth of cancers linked to viruses and other pathogens, Deputy Head of Global Oncology Dr. Thomas Uldrick is improving care for people worldwide. For example, he is currently studying why people living with HIV have a higher risk of lung cancer — potentially helping clinicians and patients intercept cancer before it starts.

Seattle Translational Tumor Research (STTR)
Check out this video from Dr. Eric Holland
Ganging up on tumors
We need cures now — so why work alone? Scientists from Fred Hutch, the University of Washington, and the Seattle Cancer Care Alliance are teaming up to save lives. Through the Seattle Translational Tumor Research group, top experts are pooling information on the most effective treatments for tumors, sharing research, and mining huge data sets to turn discoveries into therapies as quickly as possible.